STAAR Surgical Reports First Quarter Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended March 29, 2019. First Quarter 2019 Overview Net Sales of $32.6 Million Up 20% from the Prior Year Quarter ICL Sales Up 31% and Units Up 39% from the Prior Year Quarter ICL Sales Up 34% and Net Sales Up 23% on a Constant Currency Basis from the Prio

Full Story →